CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,285,829 | +19.7% | 120,603 | -2.3% | 0.00% | 0.0% |
| Q2 2023 | $2,745,539 | -14.2% | 123,395 | -16.4% | 0.00% | 0.0% |
| Q1 2023 | $3,198,901 | +12.4% | 147,687 | +5.4% | 0.00% | 0.0% |
| Q4 2022 | $2,845,066 | +2.4% | 140,082 | +29.3% | 0.00% | 0.0% |
| Q3 2022 | $2,778,000 | +9.2% | 108,328 | +1.3% | 0.00% | 0.0% |
| Q2 2022 | $2,544,000 | -5.0% | 106,983 | -10.1% | 0.00% | +50.0% |
| Q1 2022 | $2,679,000 | +25.0% | 119,002 | +9.9% | 0.00% | +100.0% |
| Q4 2021 | $2,143,000 | -5.7% | 108,249 | -6.2% | 0.00% | 0.0% |
| Q3 2021 | $2,272,000 | -16.6% | 115,387 | -6.8% | 0.00% | 0.0% |
| Q2 2021 | $2,723,000 | +8.9% | 123,769 | +17.8% | 0.00% | 0.0% |
| Q1 2021 | $2,500,000 | -19.5% | 105,068 | -11.5% | 0.00% | -50.0% |
| Q4 2020 | $3,104,000 | +116.2% | 118,661 | +43.7% | 0.00% | +100.0% |
| Q3 2020 | $1,436,000 | -1.1% | 82,575 | -4.3% | 0.00% | 0.0% |
| Q2 2020 | $1,452,000 | +34.6% | 86,320 | -4.8% | 0.00% | 0.0% |
| Q1 2020 | $1,079,000 | +42.0% | 90,667 | +44.2% | 0.00% | 0.0% |
| Q4 2019 | $760,000 | -24.6% | 62,881 | -11.8% | 0.00% | 0.0% |
| Q3 2019 | $1,008,000 | +34.9% | 71,264 | +6.4% | 0.00% | 0.0% |
| Q2 2019 | $747,000 | -13.6% | 66,983 | -9.0% | 0.00% | 0.0% |
| Q1 2019 | $865,000 | -19.2% | 73,599 | -8.2% | 0.00% | 0.0% |
| Q4 2018 | $1,071,000 | -42.4% | 80,140 | -39.5% | 0.00% | -50.0% |
| Q3 2018 | $1,858,000 | -34.6% | 132,533 | -26.6% | 0.00% | -33.3% |
| Q2 2018 | $2,839,000 | +10.4% | 180,679 | +15.6% | 0.00% | +50.0% |
| Q1 2018 | $2,572,000 | +21.2% | 156,262 | +33.0% | 0.00% | 0.0% |
| Q4 2017 | $2,122,000 | -3.9% | 117,506 | +2.7% | 0.00% | 0.0% |
| Q3 2017 | $2,208,000 | +181.3% | 114,440 | +71.8% | 0.00% | +100.0% |
| Q2 2017 | $785,000 | +60.9% | 66,598 | +49.5% | 0.00% | – |
| Q1 2017 | $488,000 | -57.0% | 44,558 | -71.5% | 0.00% | -100.0% |
| Q4 2016 | $1,134,000 | +141.3% | 156,165 | +115.8% | 0.00% | – |
| Q3 2016 | $470,000 | +3.1% | 72,360 | -13.5% | 0.00% | -100.0% |
| Q2 2016 | $456,000 | +347.1% | 83,622 | +285.8% | 0.00% | – |
| Q1 2016 | $102,000 | -78.8% | 21,676 | -77.5% | 0.00% | -100.0% |
| Q4 2015 | $480,000 | +144.9% | 96,405 | +84.5% | 0.00% | – |
| Q3 2015 | $196,000 | -46.9% | 52,260 | -14.7% | 0.00% | – |
| Q2 2015 | $369,000 | +146.0% | 61,265 | +129.4% | 0.00% | – |
| Q1 2015 | $150,000 | +150.0% | 26,705 | +33.5% | 0.00% | – |
| Q4 2014 | $60,000 | +66.7% | 20,001 | +48.5% | 0.00% | – |
| Q3 2014 | $36,000 | -12.2% | 13,465 | -8.8% | 0.00% | – |
| Q2 2014 | $41,000 | -80.9% | 14,765 | -70.0% | 0.00% | – |
| Q1 2014 | $215,000 | +73.4% | 49,284 | +27.5% | 0.00% | – |
| Q4 2013 | $124,000 | +552.6% | 38,667 | +214.6% | 0.00% | – |
| Q3 2013 | $19,000 | -32.1% | 12,290 | -23.5% | 0.00% | – |
| Q2 2013 | $28,000 | -56.9% | 16,059 | -50.7% | 0.00% | – |
| Q1 2013 | $65,000 | – | 32,591 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |